Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Merit Medical Systems (MMSI) over the last 16 years, with Q3 2025 value amounting to $50.6 million.

  • Merit Medical Systems' Net Cash Flow rose 14361.35% to $50.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$130.5 million, marking a year-over-year decrease of 12824.42%. This contributed to the annual value of -$207.9 million for FY2024, which is 13928.82% down from last year.
  • According to the latest figures from Q3 2025, Merit Medical Systems' Net Cash Flow is $50.6 million, which was up 14361.35% from -$55.7 million recorded in Q2 2025.
  • Over the past 5 years, Merit Medical Systems' Net Cash Flow peaked at $526.7 million during Q4 2023, and registered a low of -$143.3 million during Q4 2024.
  • Moreover, its 5-year median value for Net Cash Flow was -$209000.0 (2021), whereas its average is $18.0 million.
  • In the last 5 years, Merit Medical Systems' Net Cash Flow plummeted by 389377.99% in 2022 and then soared by 1058393.51% in 2023.
  • Merit Medical Systems' Net Cash Flow (Quarter) stood at -$1.3 million in 2021, then soared by 490.96% to $4.9 million in 2022, then soared by 10583.94% to $526.7 million in 2023, then plummeted by 127.2% to -$143.3 million in 2024, then surged by 135.28% to $50.6 million in 2025.
  • Its Net Cash Flow was $50.6 million in Q3 2025, compared to -$55.7 million in Q2 2025 and $17.9 million in Q1 2025.